CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non-small cell lung cancer patients - Wikidata - awgldk - TriplyDB

CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non-small cell lung cancer patients

CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non-small cell lung cancer patients

http://www.wikidata.org/entity/Q28254772

about

Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling Lung cancer stem cells-characteristics, phenotype Cancer Stem Cells: The Potential Targets of Chinese Medicines and Their Active Compounds Common stemness regulators of embryonic and cancer stem cells Reinventing diagnostics for personalized therapy in oncology Elevated expression of Nrf2 mediates multidrug resistance in CD133(+) head and neck squamous cell carcinoma stem cells Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinoma The new concepts on overcoming drug resistance in lung cancer.Lung cancer stem cell: new insights on experimental models and preclinical data.Evidence for self-renewing lung cancer stem cells and their implications in tumor initiation, progression, and targeted therapy.Presence of a putative tumor-initiating progenitor cell population predicts poor prognosis in smokers with non-small cell lung cancer.Icotinib antagonizes ABCG2-mediated multidrug resistance, but not the pemetrexed resistance mediated by thymidylate synthase and ABCG2.Stem cells and cell therapy approaches in lung biology and diseases.EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer.Hypoxia induces EMT in low and highly aggressive pancreatic tumor cells but only cells with cancer stem cell characteristics acquire pronounced migratory potential.Prognostic value of CD133 expression in stage I lung adenocarcinomas.Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry.CD133 expression is not an independent prognostic factor in stage II and III colorectal cancer but may predict the better outcome in patients with adjuvant therapy Cancer stem cell radioresistance and enrichment: where frontline radiation therapy may fail in lung and esophageal cancers High CD133 expression in the nucleus and cytoplasm predicts poor prognosis in non-small cell lung cancer Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells Is CD133 expression a prognostic biomarker of non-small-cell lung cancer? A systematic review and meta-analysis.Essential role of aldehyde dehydrogenase 1A3 for the maintenance of non-small cell lung cancer stem cells is associated with the STAT3 pathway.Role of insulin-like growth factor-1 signaling pathway in cisplatin-resistant lung cancer cells.Enhanced expression of stem cell markers and drug resistance in sphere-forming non-small cell lung cancer cells.Attenuation of lung cancer stem cell tumorigenesis and metastasis by cisplatin Epithelial-mesenchymal transition in patients of pulmonary adenocarcinoma: correlation with cancer stem cell markers and prognosis.Network biology of tumor stem-like cells identified a regulatory role of CBX5 in lung cancer.Evolving concepts in lung carcinogenesis Pharmacogenomics and cancer stem cells: a changing landscape?Epigenetic regulation of cancer stem cells in liver cancer: current concepts and clinical implications.Significance of CD133 expression in esophageal squamous cell carcinoma.CD133: a cancer stem cells marker, is used in colorectal cancers.CD133 expression may be useful as a prognostic indicator in colorectal cancer, a tool for optimizing therapy and supportive evidence for the cancer stem cell hypothesis: a meta-analysis NF-κB-driven suppression of FOXO3a contributes to EGFR mutation-independent gefitinib resistance.CD133+ cancer stem-like cells promote migration and invasion of salivary adenoid cystic carcinoma by inducing vasculogenic mimicry formation The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer Prognostic significance of stem cell-related marker expression and its correlation with histologic subtypes in lung adenocarcinoma.Clinicopathological significance of CD133 in lung cancer: A meta-analysis.Lung cancer stem cells: Molecular features and therapeutic targets.

P2860

Q24597245-EE2241FB-F04B-401D-83A2-59EE992315EF Q26740338-079F4C93-6653-4F7C-9DB6-B55187238FC5 Q26747518-EA54FA72-7569-4EFB-8066-60B7CFF0CB31 Q26777882-3A237111-CCAB-4630-966E-47343109D360 Q28391395-A91C6DC3-69D8-4795-AFD4-E36894E83A8A Q28468612-7E7843C9-4D01-46F9-80ED-98B1A78350BD Q33582684-15A21B17-3A54-42CE-8CAB-5BBC9EF38690 Q33754114-06BB8985-0570-4DD0-8CAF-F2C845B803AF Q33786637-42B68C37-30E9-472C-8F38-06EBC4C32327 Q33829820-A2EACA70-E102-4224-ACA7-B9FFE4FE31F7 Q34076616-9C6FEF71-3A40-49CD-BE29-C07913D0C272 Q34101040-2D077AB0-ABE6-4E65-AEDF-33CB5FDDB9EC Q34361245-A4E75CEF-68CA-461C-957A-3B5AF7B2128A Q34421001-4A779CA1-2B55-4151-B3DA-559EAA1AF302 Q34438815-64A37EA9-557C-4E85-8D52-BE0C30FA054A Q34467221-7ADB8ACA-615B-47D0-9A11-EB2EA2E031E2 Q34484134-C785A871-102A-40D3-829E-37E137C9BE46 Q34640685-26B5F0DC-2A80-4845-B4C3-3596C317A0CA Q34985594-19D3EC82-8DBB-4A79-BB82-7CB72D800AAC Q35068234-7EB52BCD-0495-4D83-832D-797B70D6BEA2 Q35147451-D2930FE9-07B0-4E10-91DC-6B793AC646DF Q35190239-CD7F977F-15EA-4E11-B7A7-7D3D5BE24363 Q35627749-BC1E6CAD-5B58-44C2-82BD-117A3BB8EE28 Q35734750-3E612515-6AF7-40C0-AAB8-4EDB0AC75D17 Q35918956-61E4A0D0-4A1C-4597-92DD-DCC2B02FEEFF Q36041530-2E6BB0EA-D5A4-4141-9098-9EBF78919CFE Q36095123-79D07BA9-735A-468F-B432-B18ABF477068 Q36166708-13D4D9CD-702E-4190-9002-DC4911A299FF Q36178320-67A5044E-19A1-4F78-8BB9-279C7D6D6397 Q36251549-14B685C8-5597-4DE4-8EA7-0C8FFAF02801 Q36382605-066D81E4-5698-48D3-8C0D-993A866F9E1C Q36690373-E1013350-4615-43FB-BB64-81E562E6B268 Q36819568-F07B7EFA-FF4E-4801-999B-EE9E38B042B8 Q36962860-5CD6FACE-E8BC-4F6D-85AE-4432234FA394 Q37173070-667C6578-0BDC-4EA0-A0BD-B00A15203357 Q37301739-C4B65AD2-374C-4494-9CC0-A8639B9FFDD3 Q37346067-28FB00BA-4915-4187-A4FF-80DC3B41592C Q37520600-73D8AF22-A4EB-45AE-A25F-5657EFAA1F61 Q37560821-D5C86AE7-1671-4AC8-84E7-20E1C84DB19F Q37629583-46851E0B-CA5C-4692-BD2E-F514F9ECE59A

P2860

CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non-small cell lung cancer patients

http://www.wikidata.org/entity/Q28254772

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

CD133 is indicative for a resi ...... mall cell lung cancer patients

@ast

CD133 is indicative for a resi ...... mall cell lung cancer patients

@en

CD133 is indicative for a resi ...... mall cell lung cancer patients

@nl

type

label

CD133 is indicative for a resi ...... mall cell lung cancer patients

@ast

CD133 is indicative for a resi ...... mall cell lung cancer patients

@en

CD133 is indicative for a resi ...... mall cell lung cancer patients

@nl

prefLabel

CD133 is indicative for a resi ...... mall cell lung cancer patients

@ast

CD133 is indicative for a resi ...... mall cell lung cancer patients

@en

CD133 is indicative for a resi ...... mall cell lung cancer patients

@nl

P1433

Q28254772-90D447E7-F71B-4E04-BAC8-310C5004865A

P1476

Q28254772-6AF138F9-2398-4BE5-A75E-868EF76E154E

P2093

Q28254772-0403BE15-977F-46D9-84C8-F51D2B3FF957

Q28254772-0719B4C1-1706-4E6A-B560-229523D282F5

Q28254772-48BB48A7-3560-4933-961B-C54C23DFD15B

Q28254772-5CF756FE-08DE-4F83-9501-AA0FDCEAAA4C

Q28254772-9A9F3FD7-0751-4E4E-AACE-AB76E47E7EA1

Q28254772-D01ACD03-8DD2-4AA8-BC64-1C596BEDF052

P2860

Q28254772-416B7521-30CD-4F7A-A3CB-ECB5B10DB145

Q28254772-82DE77BF-C50D-404B-8652-4F49F52E0C0E

Q28254772-8E95762C-83D9-455D-9C59-19FD0FCD713C

P304

Q28254772-CAAC52CB-92AD-44FC-89A0-97B8E3DD6254

P31

Q28254772-3F53DB77-0342-4D7A-8E9B-C0A1B5A6D060

P3181

Q28254772-2C4E6CD3-0ACC-4E4A-83B9-A7A85FB6AF41

P356

Q28254772-8D91C09F-3950-49C7-B733-FF7C82F1C5CE

P407

Q28254772-ED2E458B-A5C1-4FB1-AD64-A11D9047D4C6

P433

Q28254772-68D533FE-F4E5-4CAD-BC9B-60AF9E7ED975

P478

Q28254772-E01EE24E-AE74-4BDA-BEB6-77BFA9CD3319

P577

Q28254772-FD573994-355E-4B63-B748-6310E56403EF

P5875

Q28254772-5F976D87-493D-4323-8D25-3843286B0DB3

P698

Q28254772-2AD3791D-21F0-46A1-89A3-23CD0B5CD948

P921

Q28254772-5A9637DC-4D0C-4CE8-B907-F48455AD0F45

P3181

P356

P1433

International Journal of Cancer

P1476

CD133 is indicative for a resi ...... mall cell lung cancer patients

@en

P2093

Alexei V Salnikov

http://www.w3.org/2001/XMLSchema#string

Gerhard Moldenhauer

http://www.w3.org/2001/XMLSchema#string

Ingrid Herr

http://www.w3.org/2001/XMLSchema#string

Jury Gladkich

http://www.w3.org/2001/XMLSchema#string

Jürgen Mattern

http://www.w3.org/2001/XMLSchema#string

Manfred Volm

http://www.w3.org/2001/XMLSchema#string

P2860

Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma.

Pretherapeutic detection of tumour resistance and the results of tumour chemotherapy.

Metastatic cancer stem cells: a new target for anti-cancer therapy?

P304

950-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

997472

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/IJC.24822

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

126

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26737366

http://www.w3.org/2001/XMLSchema#string

P698

19676044

http://www.w3.org/2001/XMLSchema#string

P921